Medicare and Medicaid Waste in Focus as CMS Administrator Departs Position

The New York Times published an article this past weekend titled, “Health Official Takes Parting Shot at Waste.”  Written by Robert Pear, the article focuses on commentary from Dr. Donald M. Berwick, the newly departed former administrator of the Centers for Medicare and Medicaid Services (CMS).

Of particular interest is Dr. Berwick’s opinion that, “Twenty percent to thirty percent of health spending is “waste” that yields no benefit to patients, and that some of the needless spending is a result of onerous, archaic regulations enforced by his agency.”  The doctor’s estimates of this “waste” amounts to between $150 billion and $250 billion per year — monies that are desperately needed in reducing our country’s enormous debt problem and that could also go toward providing better health care service.

Where does this waste come from?  Examples of excessive waste abound in the Medicare and Medicaid system. Just one example: the multitude of unused diabetes test strips prescribed for patients to self-monitor their blood glucose levels.  Even though they are paid for by CMS, many of these strips are never used.  More outrageously, some of the unused test strips are even “resold” on the gray market.  This waste and even outright abuse of the system are enabled because CMS does not require adequate accountability of if these test strips are used before paying for refills.

ALR Technologies (ALRT)

We as a nation simply can’t afford to continue spending like this without better accountability and reform.  Given the state of the healthcare system and the well-publicized needs for reform, change will inevitably happen; it’s just a matter of when.  Investors will be glad to know that there are countless junior companies well-positioned to capitalize on fundamental shifts in healthcare.  ALR Technologies Inc. (OTCBB: ALRT) provides a chronic disease management technology, the Health-e-Connect System, which could provide measurable benefits to CMS and those it covers in the near term.  ALR received FDA 510(k) clearance for its Health-e-Connect System for remote monitoring of patients in support of effective diabetes management programs in October 2011.

Specifically, ALR Technologies manufactures a chronic disease management system – Health-e-Connect – that allows sharing of blood glucose data between patients and their providers. The platform is intended to improve patient outcomes, when used as part of an effective diabetes management program, by enabling providers to make immediate medication and lifestyle adjustments and to address patient barriers to diabetes care plan adherence. Improved patient outcomes equate to less health care spending. Health-e-Connect also tracks diabetes test strip utilization – information that could be used by dispensers to curb rampant test strip waste currently contributing to the squandering of millions of CMS dollars annually.

PositiveID Corp (PSID)

Possessing a similar technology, but possibly carrying upfront costs with it, PositiveID Corporation (OTCBB: PSID) received FDA clearance for its iglucose™ mobile health system for diabetes management in mid-November 2011.

The electronic medical record arena has many firms vying for space.  According to Millennium Research Group, the electronic medical record market is projected to grow from less than $1 million in 2009 to more than $8.3 billion by 2016.  Software and office equipment maker Xerox Corp. (NYSE: XRX) reported last week that its ACS subsidiary bought cloud-computing company The Breakaway Group to grow its electronic medical

MMRGlobal (MMRF)

records capacities.  At the ground-level price point, MMRGlobal Inc. (OTCBB: MMRF) is a leading junior in the electronic medical records space.  The company is conducting business with several household names to expand their products including Eastman Kodak (NYSE: EK), Alcatel-Lucent (NYSE: ALU) and privately-held Chartis, Inc.

The original NY Times article can be viewed at:

ALR Technologies (ALRT) Stock Quote and News:

PositiveID (PSID) Stock Quote and News:

MMRGlobal (MMRF) Stock Quote and News:

Disclaimer: Neither nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has been compensated twenty thousand dollars per month for three months of consultation, social media and journalism services and to manage a comprehensive investor relations/awareness program by ALR Technologies. Please read and fully understand our entire disclaimer at


Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

Dig-It Underground Stock Chart Analysis Video

Dig-It Underground Stock Chart Analysis Video(0)

A spike in volume and rise in share price has Dig-It Underground (Pink Sheets: DIGX) on the radar for more movement in the morning. A thinly-traded stock, volatility has been strong in the chart as the MACD trends upwards towards zero as the chart is making a bounce off the bottom. The Relative Strength Index

GelTech Receives First Order for FireIce from Turkey

GelTech Receives First Order for FireIce from Turkey(0)

GelTech Solutions, Inc. (OTCBB: GLTC) this morning reported receipt of the first order from Turkey through partner Nano Girisim Ltd. Sti.  Nano Girism Ltd. Sti., a distributor of industrial products based in Istanbul.  Nano Girisim intends to initially promote GelTech’s FireIce, a revolutionary water enhancing fire suppressant for use in fire extinguishers, as Turkish law

Lyris to Host Third Quarter Earnings Webcast

Lyris to Host Third Quarter Earnings Webcast(0)

Global digital marketing company Lyris, Inc. (OTCBB:LYRI) will report its operating results for the third quarter of fiscal 2012 on Thursday, May 10. The company will hold a conference call and webcast to discuss its financial results and operating activities open to all interested parties at 8 a.m., Pacific Daylight Time (11 a.m., Eastern Daylight

Athersys Meets with FDA to Discuss Suppressing GvHD in Leukemia and other Cancers

Athersys Meets with FDA to Discuss Suppressing GvHD in Leukemia and other Cancers(0)

Graft versus Host Disease (GvHD) is an area of great unmet medical that represents a significant risk to cancer patients throughout the world.  The condition occurs when patients receive a bone marrow transplant following radiation and/or chemotherapy, and the transplanted immune cells begin to attack the patient, causing significant pain and disability, or even death.

Judge Denies Taylor Armstrong’s Request to Dismiss Case with, Damages Could Grow in Excess of $3 Million

Judge Denies Taylor Armstrong’s Request to Dismiss Case with, Damages Could Grow in Excess of $3 Million(0)

In the latest round of the litigation between MMRGlobal, Inc. (OTCBB: MMRF) company (“MMR”) and Beverly Hills Housewife Taylor Armstrong, Los Angeles Superior Court Judge Frederick Shaller dealt a blow to Taylor Armstrong in denying her motion for a summary judgment to have the lawsuit against her dismissed. We first broke the story

read more

Stay Informed

Receive the OTCS Newsletter *


* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

© 2011 Viper Enterprises, LLC. All rights reserved.